Onyx Pharmaceuticals Company Profile

07:44 EDT 24th March 2018 | BioPortfolio

Onyx Pharmaceuticals, Inc. is engaged in the discovery and development of novel therapeutics based upon the genetics of human disease, with an emphasis on cancer. The Company's strategy is to capitalize on the discoveries that have established cancer as a genetic disease. When certain genes are mutated, cells grow and proliferate unchecked and become resistant to internal mechanisms that would normally cause their death. The Company's drug discovery and development programs focus on innovative therapies that target the most frequent mutations causing cancer.


2100 Powell Street
United States of America


Phone: 510.597.6500
Fax: 510.597.6600

News Articles [486 Associated News Articles listed on BioPortfolio]

Crepidula onyx resilient towards microplastic diet

(Hong Kong University of Science and Technology) A group of scientists at the Chan Lab of the Division of Life Science, HKUST, uses Crepdiula onyx as a model organism to test microplastics immunity, ...

Development of Eye Disease Combination Therapy Halted by Regeneron, Bayer After Phase II Failures

Regeneron said today it has halted co-development with Bayer of a therapy combining the companies’ marketed treatment Eylea® (aflibercept) and Regeneron’s nesvacumab—an up-to-$130 million-p...

Onyx Health wins two new accounts

Newcells Biotech and HeartScan appoint marketing comms agency

Regeneron Drops Eylea Combination After Phase 2 Failures

TARRYTOWN, N.Y., Nov. 27, 2017 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that results from two Phase 2 studies that added the angiopoietin2 (Ang2) antibo...

Medtronic Launches First 2.0 mm Drug-Eluting Stent in United States Designed to Treat Patients with Small Vessels

FDA Approved, Resolute Onyx 2.0 mm DES Technology Tackles Clinical Challenge of Treating Coronary Artery Disease in Previously Untreatable Patients DUBLIN - February 26, 2018 - Design...

2018 Onyx Magnetic Beauty Mask Ushers in New Era in Skin Care

A growing number of popular beauty bloggers, including an associate editor at Vogue, are embracing the new 2018 Onyx Magnetic Beauty Mask -- a new entry into the crowded facial beauty mask market, acc...

FDA grants Medtronic approvals for DES, CGM

Medtronic obtained approval from the FDA for its Resolute Onyx 2.0 mm drug-eluting stent, which expands to 3.25 mm upon deplo -More- 

Onyx M.D. Wins Inavero’s 2018 Best of Staffing® Client Award

For four years straight, the physician staffing firm averaged client satisfaction scores more than three times higher than the industry average. DENVER (PRWEB) February 16, 2018 Onyx M.D., a leading ...

Drugs and Medications [270 Associated Drugs and Medications listed on BioPortfolio]

Pur-wash [Niagara Pharmaceuticals Inc.]


Bacitracin [Qualitest Pharmaceuticals]

Bacitracin Ointment, USP

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash Purified Water, 98.3% Ophthalmic Solution Eyewash

Antacid [Major Pharmaceuticals]

Major Pharmaceuticals Antacid Tablets Drug Facts

Eyewash station additive concentrate [Niagara Pharmaceuticals Inc.]


PubMed Articles [131 Associated PubMed Articles listed on BioPortfolio]

Safety and efficacy of the next generation Resolute Onyx zotarolimus-eluting stent: Primary outcome of the RESOLUTE ONYX core trial.

To assess the safety and efficacy of the novel Resolute (R-) Onyx drug-eluting stent (DES).

An Onyx tunnel: reconstructive transvenous balloon-assisted Onyx embolization for dural arteriovenous fistula of the transverse-sigmoid sinus.

Transvenous embolization is an effective method for treating dural arteriovenous fistulas (DAVFs) of the transverse-sigmoid sinus (TSS). However, in cases of complicated DAVFs, it is difficult to pres...

Combined use of coils and Onyx for transcatheter closure of coronary artery fistula.

To evaluate the safety and efficacy of combined of endovascular coiling as well as Onyx embolization in patients with coronary artery fistula (CAF).

Transarterial Onyx Embolization of Intracranial Dural Fistulas: A Prospective Cohort, Systematic review, and Meta-Analysis.

Onyx is important embolic material in the endovascular treatment of intracranial dural arteriovenous fistula (DAVF). However, its impact on DAVF occlusion rates, morbidity, mortality, and complication...

Safety of Onyx Transarterial Embolization of Skull Base Dural Arteriovenous Fistulas from Meningeal Branches of the External Carotids also Fed by Meningeal Branches of Internal Carotid or Vertebral Arteries.

To analyze the angiographic and clinical results of transarterial embolization with Onyx (Medtronic-Covidien, Irvine, CA) in dural arteriovenous fistulas (DAVFs) partially fed by arteries arising from...

Clinical Trials [224 Associated Clinical Trials listed on BioPortfolio]

IRIS-Onyx Cohort in the IRIS-DES Registry

The purpose of this study is to evaluate the relative effectiveness and safety of Onyx stent compared to other (drug eluting stents) DES.

Effect and Efficacy of Onyx™, Zotarolimus-eluting Stent for Coronary Atherosclerosis

The objectives of this study are 1. To establish a prospective registry of the whole patients who received percutaneous coronary intervention with Resolute Onyx™ stent. ...

ONYX-015 With Cisplatin and Fluorouracil in Treating Patients With Advanced Head and Neck Cancer

RATIONALE: A specially modified virus called ONYX-015 may be able to kill tumor cells while leaving normal cells undamaged. Drugs used in chemotherapy use different ways to stop tumor cell...

Study Comparing Onyx and TRUFILL in Brain Arteriovenous Malformations (AVMs)

Test whether AVMs treated with Onyx is equivalent to treatment with n-BCA. Success is defined as an AVM size reduction greater than 50%

RESOLUTE ONYX China Single Arm Study

It is a single arm clinical evaluation of safety and efficacy of the Medtronic Resolute Onyx™ zotarolimus-eluting coronary stent system in subjects who are eligible for percutaneous tran...

Companies [1308 Associated Companies listed on BioPortfolio]

Onyx Pharmaceuticals, Inc.

Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer. The company, in collaboration with Bayer HealthCare Pharmaceuticals, Inc., is developi...

Onyx Pharmaceuticals

Onyx Pharmaceuticals, Inc. is engaged in the discovery and development of novel therapeutics based upon the genetics of human disease, with an emphasis on cancer. The Company's strategy is to capitali...

Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc.

Contact: FOR MORE INFORMATION, PLEASE CALL: MultiVu Media Relations, 1-800-653-5313 EXT. 3

Onyx Scientific Limited

Onyx Scientific is one of the fastest growing pharmaceutical service companies in the UK. We have more than 40 expert scientists specialising in drug development from medicinal chemistry to early stag...

Onyx Environmental Services

Onyx Environmental Services is the leading provider of environmental services in the United States. Our network of service centers, treatment, recovery and disposal facilities, sales offices and trans...

More Information about "Onyx Pharmaceuticals" on BioPortfolio

We have published hundreds of Onyx Pharmaceuticals news stories on BioPortfolio along with dozens of Onyx Pharmaceuticals Clinical Trials and PubMed Articles about Onyx Pharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Onyx Pharmaceuticals Companies in our database. You can also find out about relevant Onyx Pharmaceuticals Drugs and Medications on this site too.

Quick Search


Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

Corporate Database Quicklinks

Searches Linking to this Company Record